Liposomal drug formulations for treatment of hematological malignancies

Expert Opin Pharmacother. 2023 Sep-Dec;24(18):1911-1914. doi: 10.1080/14656566.2023.2269086. Epub 2024 Jan 5.
No abstract available

Keywords: Anthracyclines; Hematological malignancies; Liposomal drug formulation; Targeted therapy.

Publication types

  • Editorial

MeSH terms

  • Doxorubicin
  • Drug Compounding
  • Hematologic Neoplasms* / drug therapy
  • Humans
  • Liposomes*

Substances

  • Liposomes
  • Doxorubicin